Manulife (Manufacturers Life Insurance)
ARCT icon

Manulife (Manufacturers Life Insurance)’s Arcturus Therapeutics ARCT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,729
Closed -$203K – 2974
2024
Q3 		$203K Sell
8,729
-219
-2% -$4.68K ﹤0.01% 2663
2024
Q2 		$218K Buy
8,948
+262
+3% +$7.95K ﹤0.01% 2571
2024
Q1 		$293K Sell
8,686
-149
-2% -$5.28K ﹤0.01% 2407
2023
Q4 		$279K Sell
8,835
-256
-3% -$6.08K ﹤0.01% 2441
2023
Q3 		$232K Sell
9,091
-167
-2% -$5.14K ﹤0.01% 2509
2023
Q2 		$266K Buy
9,258
+681
+8% +$18.5K ﹤0.01% 2443
2023
Q1 		$206K Buy
+8,577
New +$154K ﹤0.01% 2552
2022
Q2 		– Sell
-8,352
Closed -$225K – 3012
2022
Q1 		$225K Sell
8,352
-2,179
-21% -$55.6K ﹤0.01% 2692
2021
Q4 		$390 Sell
10,531
-24
-0.2% -$978 ﹤0.01% 2432
2021
Q3 		$504K Sell
10,555
-1,231
-10% -$55.2K ﹤0.01% 2279
2021
Q2 		$399K Buy
11,786
+789
+7% +$26.7K ﹤0.01% 2592
2021
Q1 		$454K Sell
10,997
-1,680
-13% -$100K ﹤0.01% 2344
2020
Q4 		$550K Buy
12,677
+3,895
+44% +$264K ﹤0.01% 2141
2020
Q3 		$377K Buy
8,782
+1,224
+16% +$60.8K ﹤0.01% 2142
2020
Q2 		$355K Buy
+7,558
New +$260K ﹤0.01% 2137

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ARCT Position: Q4 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 8,729 shares — an estimated $203K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ARCT in Q2 2020 and held it in 15 quarters. The position peaked at $550K in Q4 2020. 147 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 8,729 Arcturus Therapeutics shares in Q4 2024, an estimated $203K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 15 quarters.
  • Manulife (Manufacturers Life Insurance)'s Arcturus Therapeutics position peaked at $550K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2024, filed 14 Feb 2025.